Abstract:In this article, we develop nonparametric inference methods for comparing survival data across two samples, which are beneficial for clinical trials of novel cancer therapies where long-term survival is a critical outcome. These therapies, including immunotherapies or other advanced treatments, aim to establish durable effects. They often exhibit distinct survival patterns such as crossing or delayed separation and potentially leveling-off at the tails of survival curves, clearly violating the proportional hazards assumption and rendering the hazard ratio inappropriate for measuring treatment effects. The proposed methodology utilizes the mixture cure framework to separately analyze the cure rates of long-term survivors and the survival functions of susceptible individuals. We evaluate a nonparametric estimator for the susceptible survival function in the one-sample setting. Under sufficient follow-up, it is expressed as a location-scale-shift variant of the Kaplan-Meier (KM) estimator. It retains several desirable features of the KM estimator, including inverse-probability-censoring weighting, product-limit estimation, self-consistency, and nonparametric efficiency. In scenarios of insufficient follow-up, it can easily be adapted by incorporating a suitable cure rate estimator. In the two-sample setting, besides using the difference in cure rates to measure the long-term effect, we propose a graphical estimand to compare the relative treatment effects on susceptible subgroups. This process, inspired by Kendall's tau, compares the order of survival times among susceptible individuals. The proposed methods' large-sample properties are derived for further inference, and the finite-sample properties are examined through extensive simulation studies. The proposed methodology is applied to analyze the digitized data from the CheckMate 067 immunotherapy clinical trial.

A Change-Point Model for Survival Data with Long-Term Survivors

Multiple Change-Point Detection in Piecewise Exponential Hazard Regression Models with Long-Term Survivors and Right Censoring

Pseudo-Maximum Likelihood Estimation in the Hazards Cure Model with a Single Change Point for Current Status Data

Estimation in the Single Change-Point Hazard Function for Interval-Censored Data with a Cure Fraction

Copula-based Semiparametric Nonnormal Transformed Linear Model for Survival Data with Dependent Censoring

Efficient estimation of Cox model with random change point

Change Point Detection in Cox Proportional Hazards Mixture Cure Model

Wavelet Detection of Change Points in Hazard Rate Models with Censored Dependent Data

On semiparametric transformation cure models

On the Maximum Penalized Full Likelihood Approach for Cox Model with Extreme Value for Heavily Censored Survival Data

A Semiparametric Change-Point Regression Model for Longitudinal Observations

Wavelet Analysis of Change Points in Nonparametric Hazard Rate Models under Random Censorship

Analyzing Left-Truncated and Right-Censored Data under Cox Models with Long-Term Survivors

Multiple random change points in survival analysis with applications to clinical trials

An Online Updating Approach for Testing the Proportional Hazards Assumption with Streams of Survival Data

Bayesian analyses of multiple random change points in survival models with applications to clinical trials

Joint Modeling of Longitudinal and Survival Data with Censored Single-index Varying Coefficient Models

Estimand-based Inference in Presence of Long-Term Survivors

Non-parametric cure rate estimation under insufficient follow-up using extremes

Frailty model with change points for survival analysis

Testing for Sufficient Follow‐Up in Censored Survival Data by Using Extremes